Bertrand, D.; Laurent, C.; Lemoine, M.; Lebourg, L.; Hanoy, M.; Le Roy, F.; Nezam, D.; Pruteanu, D.; Grange, S.; De Nattes, T.;
et al. Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose. Microorganisms 2024, 12, 722.
https://doi.org/10.3390/microorganisms12040722
AMA Style
Bertrand D, Laurent C, Lemoine M, Lebourg L, Hanoy M, Le Roy F, Nezam D, Pruteanu D, Grange S, De Nattes T,
et al. Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose. Microorganisms. 2024; 12(4):722.
https://doi.org/10.3390/microorganisms12040722
Chicago/Turabian Style
Bertrand, Dominique, Charlotte Laurent, Mathilde Lemoine, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan De Nattes,
and et al. 2024. "Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose" Microorganisms 12, no. 4: 722.
https://doi.org/10.3390/microorganisms12040722
APA Style
Bertrand, D., Laurent, C., Lemoine, M., Lebourg, L., Hanoy, M., Le Roy, F., Nezam, D., Pruteanu, D., Grange, S., De Nattes, T., Lemée, V., Guerrot, D., & Candon, S.
(2024). Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose. Microorganisms, 12(4), 722.
https://doi.org/10.3390/microorganisms12040722
